Papers - NIIOKA Takenori
-
Impact of polymorphisms of pharmacokinetics-related genes and the inflammatory response on the metabolism of voriconazole.
Naoya Aiuchi, Junichi Nakagawa, Hirotake Sakuraba, Takenori Takahata, Kosuke Kamata, Norihiro Saito, Kayo Ueno, Masahiro Ishiyama, Kazufumi Yamagata, Hiroyuki Kayaba, Takenori Niioka
Pharmacology research & perspectives 10 ( 2 ) e00935 2022.4
-
免疫抑制剤TDM実施において考慮すべき点
三浦 昌朋, 見野 靖晃, 本間 真人, 新岡 丈典, 竹内 裕紀
日本臨床腎移植学会雑誌 9 ( 2 ) 149 - 156 2021.12
-
Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation.
Junichi Nakagawa, Takahiko Kinjo, Mei Iizuka, Kayo Ueno, Hirofumi Tomita, Takenori Niioka
Basic & clinical pharmacology & toxicology 128 ( 2 ) 297 - 304 2021.2
-
Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy.
Junichi Nakagawa, Takenori Takahata, Rui Hyodo, Yu Chen, Kengo Hasui, Kota Sasaki, Kensuke Saito, Kayo Ueno, Kazuhiro Hosoi, Kazufumi Terui, Atsushi Sato, Takenori Niioka
Scientific reports 11 ( 1 ) 785 - 785 2021.1
-
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.
Hisashi Tanaka, Kageaki Taima, Tomonori Makiguchi, Junichi Nakagawa, Takenori Niioka, Sadatomo Tasaka
Cancer communications (London, England) 41 ( 1 ) 83 - 87 2021.1
-
注射用抗がん薬使用状況調査に基づく医療費削減のためのdrug vial optimization実施方法に関する検討
照井 一史, 兵藤 塁, 中川 潤一, 細井 一広, 小原 信一, 本間 聖明, 明石 真弓, 佐藤 和洋, 矢田 康司, 宮崎 晃臣, 田中 南美英, 神 雅昭, 中村 一成, 山本 章二, 田村 健悦, 新岡 丈典
日本病院薬剤師会雑誌 = Journal of Japanese Society of Hospital Pharmacists 56 ( 12 ) 1445 - 1451 2020.12
-
Cyclosporine protects from intestinal epithelial injury by modulating butyrate uptake via upregulation of membrane monocarboxylate transporter 1 levels.
Shinji Ota, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Miwa Satake, Yui Akemoto, Nahoko Tanaka, Rina Watanabe, Maeda Takato, Yasuhisa Murai, Kayo Ueno, Takenori Niioka, Makoto Hayakari, Yoh Ishiguro, Shinsaku Fukuda
Biochemistry and biophysics reports 24 100811 - 100811 2020.12
-
注射用抗がん薬使用状況調査に基づく医療費削減のためのdrug vial optimization実施方法に関する検討
照井 一史, 兵藤 塁, 中川 潤一, 細井 一広, 小原 信一, 本間 聖明, 明石 真弓, 佐藤 和洋, 矢田 康司, 宮崎 晃臣, 田中 南美英, 神 雅昭, 中村 一成, 山本 章二, 田村 健悦, 新岡 丈典
日本病院薬剤師会雑誌 56 ( 12 ) 1445 - 1451 2020.12
-
Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation.
Junichi Nakagawa, Keinosuke Ishido, Yuka Tono, Norihisa Kimura, Taiichi Wakiya, Yuji Okamura, Kenichi Hakamada, Takenori Niioka
European journal of drug metabolism and pharmacokinetics 45 ( 5 ) 619 - 626 2020.10
-
3系統以上の抗菌薬に耐性を示す緑膿菌サーベイランスにおけるAntibiotic Heterogeneity Indexの有用性に関する検討
東野 優花, 岡村 祐嗣, 津山 博匡, 井上 文緒, 齋藤 紀先, 萱場 広之, 新岡 丈典
日本病院薬剤師会雑誌 = Journal of Japanese Society of Hospital Pharmacists 56 ( 7 ) 791 - 796 2020.7
-
3系統以上の抗菌薬に耐性を示す緑膿菌サーベイランスにおけるAntibiotic Heterogeneity Indexの有用性に関する検討
東野 優花, 岡村 祐嗣, 津山 博匡, 井上 文緒, 齋藤 紀先, 萱場 広之, 新岡 丈典
日本病院薬剤師会雑誌 56 ( 7 ) 791 - 796 2020.7
-
Association of lenvatinib trough plasma concentrations with lenvatinib-induced toxicities in Japanese patients with thyroid cancer.
Mitsuji Nagahama, Tomoko Ozeki, Akifumi Suzuki, Kiminori Sugino, Takenori Niioka, Koichi Ito, Masatomo Miura
Medical oncology (Northwood, London, England) 36 ( 5 ) 39 - 39 2019.3
-
The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma.
Kobayashi Takahiro, Miura Masatomo, Abumiya Maiko, Niioka Takenori, Kanno Shuichi, Takahashi Naoto
Ann Hematol 97 ( 6 ) 1097 - 1099 2018.6
-
Phase II Clinical Trial of Lenalidomide and Dexamethasone Therapy in Japanese Elderly Patients With Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide.
Kobayashi Takahiro, Miura Masatomo, Niioka Takenori, Abumiya Maiko, Ito Fumiko, Kobayashi Isuzu, Ikeda Sho, Yoshioka Tomoko, Kameoka Yoshihiro, Takahashi Naoto
Ther Drug Monit 40 ( 3 ) 301 - 309 2018.6
-
Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.
Numakura Kazuyuki, Fujiyama Nobuhiro, Takahashi Makoto, Igarashi Ryoma, Tsuruta Hiroshi, Maeno Atsushi, Huang Mingguo, Saito Mitsuru, Narita Shintaro, Inoue Takamitsu, Satoh Shigeru, Tsuchiya Norihiko, Niioka Takenori, Miura Masatomo, Habuchi Tomonori
Oncotarget 9 ( 38 ) 25277 - 25284 2018.5
-
Influence of CYP3A5 genetic differences in tacrolimus on quantitative interstitial fibrosis and long-term graft function in kidney transplant recipients.
Komine Naoki, Satoh Shigeru, Saito Mitsuru, Numakura Kazuyuki, Inoue Takamitsu, Tsuruta Hiroshi, Narita Shintaro, Komatsuda Atsushi, Nanjo Hiroshi, Kagaya Hideaki, Niioka Takenori, Miura Masatomo, Mitobe Yoko, Habuchi Tomonori
Int Immunopharmacol 58 57 - 63 2018.5
-
Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients.
Kagaya Hideaki, Niioka Takenori, Saito Mitsuru, Inoue Takamitsu, Numakura Kazuyuki, Yamamoto Ryohei, Akamine Yumiko, Habuchi Tomonori, Satoh Shigeru, Miura Masatomo
Int J Mol Sci 19 ( 3 ) 2018.3
-
Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.
Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomonori
Med Oncol 35 ( 4 ) 51 - 51 2018.3
-
Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia.
Mita Akiko, Abumiya Maiko, Miura Masatomo, Niioka Takenori, Takahashi Saori, Yoshioka Tomoko, Kameoka Yoshihiro, Takahashi Naoto
Exp Hematol Oncol 7 9 - 9 2018
-
Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes.
Niioka Takenori, Fujishima Naohito, Abumiya Maiko, Yamashita Takaya, Ubukawa Kumi, Nara Miho, Fujishima Masumi, Takahashi Naoto, Miura Masatomo
Ther Drug Monit 39 ( 5 ) 514 - 521 2017.10